Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Inflammatory process in Parkinson disease: neuroprotection by Neuropeptide Y.

Pain S, Bodard S, Gulhan Z, Vergote J, Chalon S, Gaillard A.

Fundam Clin Pharmacol. 2019 Mar 13. doi: 10.1111/fcp.12464. [Epub ahead of print]

PMID:
30866091
2.

Frequency and factors related to drooling in Chinese patients with multiple system atrophy: a cross-sectional study.

Chen Y, Huang H, Ning P, Zhao Q, Wang H, Shen Q, Xu Y.

Clin Auton Res. 2019 Mar 12. doi: 10.1007/s10286-019-00602-2. [Epub ahead of print]

PMID:
30864043
3.

A systematic review and meta-analysis of the associations of vitamin D receptor genetic variants with two types of most common neurodegenerative disorders.

Geng J, Zhang J, Yao F, Liu X, Liu J, Huang Y.

Aging Clin Exp Res. 2019 Mar 12. doi: 10.1007/s40520-019-01135-4. [Epub ahead of print]

PMID:
30863943
4.

Screening for Problematic Internet Use May Help Identify Impulse Control Disorders in Parkinson's Disease.

Kovács M, Makkos A, Pintér D, Juhász A, Darnai G, Karádi K, Janszky J, Kovács N.

Behav Neurol. 2019 Feb 3;2019:4925015. doi: 10.1155/2019/4925015. eCollection 2019.

5.

Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice.

Skowronek C, Zange L, Lipp A.

Front Neurol. 2019 Feb 26;10:152. doi: 10.3389/fneur.2019.00152. eCollection 2019.

6.

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence.

Schirinzi T, Martella G, Imbriani P, Di Lazzaro G, Franco D, Colona VL, Alwardat M, Sinibaldi Salimei P, Mercuri NB, Pierantozzi M, Pisani A.

Front Neurol. 2019 Feb 26;10:148. doi: 10.3389/fneur.2019.00148. eCollection 2019.

7.

Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease.

Eisinger RS, Ramirez-Zamora A, Carbunaru S, Ptak B, Peng-Chen Z, Okun MS, Gunduz A.

Front Neurol. 2019 Feb 26;10:86. doi: 10.3389/fneur.2019.00086. eCollection 2019. Review.

8.

Effectiveness of Integrative Therapy for Parkinson's Disease Management.

Woo Y, Hyun MK.

Front Aging Neurosci. 2019 Feb 26;11:40. doi: 10.3389/fnagi.2019.00040. eCollection 2019.

9.

Lack of Association Between DJ-1 Gene Promoter Polymorphism and the Risk of Parkinson's Disease.

He L, Lin S, Pan H, Shen R, Wang M, Liu Z, Sun S, Tan Y, Wang Y, Chen S, Ding J.

Front Aging Neurosci. 2019 Feb 26;11:24. doi: 10.3389/fnagi.2019.00024. eCollection 2019.

10.

Core Concept: Can deep brain stimulation find success beyond Parkinson's disease?

Shen HH.

Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):4764-4766. doi: 10.1073/pnas.1900442116. No abstract available.

11.

Canadian neurosurgeons' views on medical assistance in dying (MAID): a cross-sectional survey of Canadian Neurosurgical Society (CNSS) members.

Althagafi A, Ekong C, Wheelock BW, Moulton R, Gorman P, Reddy K, Christie S, Fleetwood I, Barry S.

J Med Ethics. 2019 Mar 12. pii: medethics-2018-105160. doi: 10.1136/medethics-2018-105160. [Epub ahead of print]

PMID:
30862709
12.

Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein.

Harischandra DS, Rokad D, Neal ML, Ghaisas S, Manne S, Sarkar S, Panicker N, Zenitsky G, Jin H, Lewis M, Huang X, Anantharam V, Kanthasamy A, Kanthasamy AG.

Sci Signal. 2019 Mar 12;12(572). pii: eaau4543. doi: 10.1126/scisignal.aau4543.

PMID:
30862700
13.

Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments.

Jakobs M, Fomenko A, Lozano AM, Kiening KL.

EMBO Mol Med. 2019 Mar 12. pii: e9575. doi: 10.15252/emmm.201809575. [Epub ahead of print] Review.

14.

Statistical Shape Analysis of Subthalamic Nucleus in Patients with Parkinson's Disease.

Kaya MO, Ozturk S, Ercan I, Gonen M, Kocabicak E, Erol FS.

World Neurosurg. 2019 Mar 9. pii: S1878-8750(19)30603-5. doi: 10.1016/j.wneu.2019.02.180. [Epub ahead of print]

PMID:
30862597
15.

Complex I syndrome in striatum and frontal cortex in a rat model of Parkinson disease.

Valdez LB, Zaobornyj T, Bandez MJ, López-Cepero JM, Boveris A, Navarro A.

Free Radic Biol Med. 2019 Mar 9;135:274-282. doi: 10.1016/j.freeradbiomed.2019.03.001. [Epub ahead of print]

PMID:
30862545
16.

Thalamocortical dynamics underlying spontaneous transitions in beta power in Parkinsonism.

Reis C, Sharott A, Magill PJ, van Wijk BCM, Parr T, Zeidman P, Friston KJ, Cagnan H.

Neuroimage. 2019 Mar 9;193:103-114. doi: 10.1016/j.neuroimage.2019.03.009. [Epub ahead of print]

17.

French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).

Marques A, Vidal T, Pereira B, Benchetrit E, Socha J, Pineau F, Elbaz A, Artaud F, Mangone G, You H, Cormier F, Galitstky M, Pomies E, Rascol O, Derkinderen P, Weintraub D, Corvol JC, Durif F; DIGPD study group.

Parkinsonism Relat Disord. 2019 Mar 4. pii: S1353-8020(19)30072-0. doi: 10.1016/j.parkreldis.2019.02.026. [Epub ahead of print]

PMID:
30862454
18.

Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus.

Mallach A, Weinert M, Arthur J, Gveric D, Tierney TS, Alavian KN.

FASEB J. 2019 Mar 12:fj201802628R. doi: 10.1096/fj.201802628R. [Epub ahead of print]

PMID:
30862197
19.

Water-soluble CoQ10 as A Promising Anti-aging Agent for Neurological Dysfunction in Brain Mitochondria.

Takahashi M, Takahashi K.

Antioxidants (Basel). 2019 Mar 11;8(3). pii: E61. doi: 10.3390/antiox8030061. Review.

20.

Eight Weeks of Aerobic Interval Training Improves Psychomotor Function in Patients with Parkinson's Disease-Randomized Controlled Trial.

Marusiak J, Fisher BE, Jaskólska A, Słotwiński K, Budrewicz S, Koszewicz M, Kisiel-Sajewicz K, Kamiński B, Jaskólski A.

Int J Environ Res Public Health. 2019 Mar 11;16(5). pii: E880. doi: 10.3390/ijerph16050880.

Supplemental Content

Loading ...
Support Center